[{"Assets_0_Q3_USD":855641000.0,"CommonStockSharesOutstanding_0_Q3_shares":84847000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-58679000.0,"NetIncomeLoss_1_Q3_USD":-42556000.0,"NetIncomeLoss_3_Q3_USD":-107373000.0,"StockholdersEquity_0_Q3_USD":471311000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":29027000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":104903000.0,"Ticker":"FGEN","CIK":"921299","name":"FIBROGEN INC","OfficialName":"FibroGen Inc Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"987680900.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]